(Q51029993)

27 March 2018

title

Blood lead levels in relation to cognitive function in older U.S. adults (English)

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

31 August 2024

author

Deborah A Cory-Slechta

3

object named as

Deborah A Cory-Slechta

1 reference

27 March 2018

Edwin van Wijngaarden

1

object named as

Edwin van Wijngaarden

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21093481

31 August 2024

author name string

Paul C. Winters

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21093481

31 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21093481

31 August 2024

publication date

17 November 2010

1 reference

27 March 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0161813X10002202?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

https://api.elsevier.com/content/article/PII:S0161813X10002202?httpAccept=text/plain

31 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

31 August 2024

1 reference

27 March 2018

volume

32

1 reference

27 March 2018

issue

1

1 reference

27 March 2018

page(s)

110-115

1 reference

27 March 2018

Blood lead, serum homocysteine, and neurobehavioral test performance in the third National Health and Nutrition Examination Survey

cites work

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.NEURO.2008.12.014

Low level lead exposure and oxidative stress: current opinions.

1

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Lead (Pb) exposure and its effect on APP proteolysis and Abeta aggregation

31 August 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain.

31 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Estimated prevalence of people with cognitive impairment: results from nationally representative community and institutional surveys

31 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Exposure to lead and the developmental origin of oxidative DNA damage in the aging brain

31 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Injuries among US adults with disabilities

31 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Targeting lead in the multimedia environment in the continental United States.

31 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

IQ and blood lead from 2 to 7 years of age: are the effects in older children the residual of high blood lead concentrations in 2-year-olds?

31 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Diagnosis and treatment of dementia: introduction. Introducing a series based on the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia

31 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia

31 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Lead exposure during advanced age: alterations in kinetics and biochemical effects

31 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Lifetime consequences of combined maternal lead and stress.

31 August 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Measuring cognitive function with age: the influence of selection by health and survival

31 August 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Diagnosis and treatment of dementia: 2. Diagnosis

31 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study

31 August 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Environmental lead contamination in Miami inner-city area

31 August 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Cigarette smoking and dementia: potential selection bias in the elderly

31 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Age of greatest susceptibility to childhood lead exposure: a new statistical approach

31 August 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men. The normative aging study

31 August 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms

31 August 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Self-rated health and mortality: a review of twenty-seven community studies

31 August 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

The relationship between blood lead levels and neurobehavioral test performance in NHANES III and related occupational studies

31 August 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Neurobehavioral test performance in the third National Health and Nutrition Examination Survey

31 August 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Environmental Exposures to Lead and Urban Children's Blood Lead Levels

31 August 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Low-level environmental lead exposure and children's intellectual function: an international pooled analysis

31 August 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

The effect of lead-based paint hazard remediation on blood lead levels of lead poisoned children in New York City

31 August 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Lead content and exposure from children's and adult's jewelry products

31 August 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Soil is an important pathway of human lead exposure

31 August 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Effects of blood lead levels on cognitive function of older women

31 August 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys

31 August 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Lead exposure and cardiovascular disease--a systematic review

31 August 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease

31 August 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Relation between cognitive function and mortality in middle-aged adults: the atherosclerosis risk in communities study

31 August 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Relations of bone and blood lead to cognitive function: the VA Normative Aging Study.

31 August 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

31 August 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies

31 August 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Toxicokinetics of bone lead

31 August 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Developmental lead neurotoxicity: alterations in brain cholinergic system

31 August 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Using geographic information systems to assess risk for elevated blood lead levels in children

31 August 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Spanish version of the Bayer Activities of Daily Living scale in mild cognitive impairment and mild Alzheimer disease: discriminant and concurrent validity

31 August 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Environmental lead exposure and cognitive function in community-dwelling older adults

31 August 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead

31 August 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Do neuropsychological tests have the same meaning in Spanish speakers as they do in English speakers?

31 August 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Bone lead levels are associated with measures of memory impairment in older adults

31 August 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Mechanisms of lead-induced hypertension and cardiovascular disease

31 August 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Cardiovascular effects of lead exposure

31 August 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Effects of Pb2+ on muscarinic modulation of glutamatergic synaptic transmission in rat hippocampal CA1 area.

31 August 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Cumulative lead exposure and cognitive performance among elderly men

31 August 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Cumulative lead exposure and prospective change in cognition among elderly men: the VA Normative Aging Study

31 August 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Cumulative exposure to lead in relation to cognitive function in older women

31 August 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

New and evolving concepts in the neurotoxicology of lead

31 August 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Lead exposure biomarkers and mini-mental status exam scores in older men

31 August 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD.

31 August 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the Health ABC study

31 August 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.NEURO.2010.11.002

31 August 2024

Identifiers

1 reference

27 March 2018

1 reference

27 March 2018